Table 1:
Population specifications
BMI Levela | Under-Normal -Overweightb |
Class I | Class II | Class III | Total Sample |
---|---|---|---|---|---|
N | 39,621 | 11,597 | 5,193 | 3,438 | 59,849 |
% Percentage | 66.20 | 19.38 | 8.68 | 5.74 | 100.00 |
Demographics | |||||
% Female | 59.34 | 48.66 | 57.42 | 66.67 | 57.53 |
Age in 2012 | 44.44 | 47.55 | 47.72 | 47.42 | 45.50 |
% Age 20–34 | 24.73 | 15.05 | 14.54 | 14.89 | 21.41 |
% Age 35–44 | 21.06 | 20.77 | 20.99 | 21.32 | 21.01 |
% Age 45–54 | 27.79 | 31.84 | 31.25 | 32.34 | 29.13 |
% Age 55–64 | 26.42 | 32.34 | 33.22 | 31.44 | 28.45 |
Comorbidity in 2012c | |||||
Charlson Index | 0.13 | 0.19 | 0.22 | 0.28 | 0.16 |
# Chronic Conditions | 1.63 | 2.27 | 2.61 | 3.14 | 1.92 |
# Rx Ingredients | 3.11 | 3.82 | 4.40 | 4.92 | 3.46 |
Dx-PM Score | 1.11 | 1.31 | 1.45 | 1.62 | 1.21 |
% Type-1 Diabetes | 1.05 | 1.07 | 1.23 | 0.70 | 1.05 |
% Type-2 Diabetes | 2.76 | 9.18 | 14.08 | 20.19 | 5.99 |
% Hypertension | 11.68 | 26.33 | 34.07 | 40.55 | 18.12 |
% Ischemic Heart | 1.33 | 2.95 | 2.79 | 2.39 | 1.83 |
% Acute Myocardial Infarction | 0.19 | 0.33 | 0.33 | 0.15 | 0.23 |
% Obesityd | 0.50 | 8.15 | 18.14 | 35.19 | 5.51 |
Utilization | |||||
# IP in 2012 | 0.04 | 0.06 | 0.06 | 0.07 | 0.05 |
# ED in 2012 | 0.13 | 0.17 | 0.17 | 0.21 | 0.14 |
% Any IP in 2012 | 3.21 | 4.65 | 4.81 | 5.67 | 3.77 |
% Any ED in 2012 | 10.06 | 12.51 | 13.15 | 15.68 | 11.13 |
% Top 5% cost in 2012 | 4.30 | 5.85 | 6.64 | 7.82 | 5.01 |
# IP in 2013 | 0.03 | 0.05 | 0.06 | 0.09 | 0.04 |
# ED in 2013 | 0.11 | 0.14 | 0.16 | 0.20 | 0.12 |
% Any IP in 2013 | 2.54 | 3.96 | 4.56 | 7.04 | 3.25 |
% Any ED in 2013 | 8.60 | 10.55 | 12.75 | 14.51 | 9.68 |
% Top 5% cost in 2013 | 4.00 | 5.87 | 7.36 | 10.15 | 5.01 |
Cost in $e | |||||
Total Cost in 2012 | 4618 | 5625 | 6247 | 7158 | 5100 |
Medical cost in 2012 | 3880 | 4731 | 5114 | 5901 | 4268 |
Pharmacy in 2012 | 695 | 870 | 1096 | 1223 | 794 |
Total Cost in 2013 | 4333 | 5572 | 6336 | 7957 | 4955 |
Medical cost in 2013 | 3551 | 4613 | 5126 | 6516 | 4064 |
Pharmacy in 2013 | 741 | 940 | 1176 | 1363 | 853 |
statistical significance of utilization differences among different BMI-levels was not calculated as p-value is not very informative in large populations (i.e., all p-values were significant at .001 level);
under 587 (0.98%), normal 19,162 (32.02%), and overweight 19,872 (33.20%);
generated by the ACG system using diagnosis codes of both claims and EHR data;
diagnosis of obesity captured as a diagnostic code in the EHR and/or claims; and,
cost is truncated at top 0.5%.
ED: Emergency Department; IP: Inpatient; Rx: Medication